Anteris Technologies Global Corp. (ASX:AVR)
8.07
+0.29 (3.73%)
Feb 11, 2026, 4:10 PM AEST
ASX:AVR Revenue
Anteris Technologies Global had revenue of $429.00K USD in the quarter ending September 30, 2025, a decrease of -44.21%. This brings the company's revenue in the last twelve months to $2.14M, down -21.11% year-over-year. In the year 2024, Anteris Technologies Global had annual revenue of $2.70M, down -1.17%.
Revenue (ttm)
$2.14M
Revenue Growth
-21.11%
P/S Ratio
233.91
Revenue / Employee
$15.73K
Employees
136
Market Cap
756.47M AUD
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.70M | -32.00K | -1.17% |
| Dec 31, 2023 | 2.74M | -384.72K | -12.33% |
| Dec 31, 2022 | 3.12M | -2.55M | -44.93% |
| Dec 31, 2021 | 5.66M | 203.73K | 3.73% |
| Dec 31, 2020 | 5.46M | -6.54M | -54.48% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PolyNovo | 128.70M |
| SomnoMed | 111.49M |
| Aroa Biosurgery | 79.26M |
| Compumedics | 51.04M |
| Nova Eye Medical | 29.27M |
| CleanSpace Holdings | 19.76M |
| Lumos Diagnostics Holdings | 18.91M |
| Micro-X | 13.05M |
Anteris Technologies Global News
- 20 days ago - Anteris Technologies Surges On Pricing Of $200Mln Public Offering - Nasdaq
- 20 days ago - What Sparked Anteris Technologies (AVR) Stock Surge Over 52% After-Hours? - Benzinga
- 20 days ago - Anteris Prices $200 Mln Public Offering; Announces Medtronic Private Placement Up To $90 Mln - Nasdaq
- 20 days ago - Anteris Technologies Global prices $200M public offering and concurrent $90M Medtronic placement - Seeking Alpha
- 21 days ago - Anteris Technologies proposes $200M stock offering, plans Medtronic investment - Seeking Alpha
- 3 months ago - Anteris Technologies (AVR) Reports Promising Results for DurAVR THV in Aortic Stenosis - GuruFocus
- 3 months ago - Sio Capital Management, LLC Reduces Stake in Anteris Technologies Global Corp - GuruFocus
- 3 months ago - Anteris Technologies (AVR) Reports Promising One-Year Results for DurAVR Heart Valve - GuruFocus